AOXG Stock Overview
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Aoxing Pharmaceutical Company, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0049 |
52 Week High | US$0.014 |
52 Week Low | US$0.001 |
Beta | 0 |
1 Month Change | -23.44% |
3 Month Change | 6.52% |
1 Year Change | 390.00% |
3 Year Change | -70.12% |
5 Year Change | -81.15% |
Change since IPO | -99.97% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
AOXG | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 4.3% | -0.007% | 1.0% |
1Y | 390.0% | 25.3% | 31.2% |
Return vs Industry: AOXG exceeded the US Pharmaceuticals industry which returned 23.4% over the past year.
Return vs Market: AOXG exceeded the US Market which returned 27.7% over the past year.
Price Volatility
AOXG volatility | |
---|---|
AOXG Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AOXG's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine AOXG's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Zhenjiang Yue | https://axzyen.icm.cn |
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China. The company’s principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain.
Aoxing Pharmaceutical Company, Inc. Fundamentals Summary
AOXG fundamental statistics | |
---|---|
Market cap | US$373.43k |
Earnings (TTM) | -US$1.46m |
Revenue (TTM) | US$30.11m |
0.0x
P/S Ratio0.0x
P/E RatioIs AOXG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AOXG income statement (TTM) | |
---|---|
Revenue | US$30.11m |
Cost of Revenue | US$7.17m |
Gross Profit | US$22.94m |
Other Expenses | US$24.40m |
Earnings | -US$1.46m |
Last Reported Earnings
Mar 31, 2017
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did AOXG perform over the long term?
See historical performance and comparison